Reserpine - Moligand™, 10mM in DMSO , Synaptic vesicular amine transporter inhibitor, CAS No.50-55-5, Synaptic vesicular amine transporter inhibitor

CAS: 50-55-5 Cat. No.: R408290 분자식: C33H40N2O9 분자량: 608.68 Beilstein Registry Number: 102014 EC 번호: 200-047-9 PubChem CID: 5770
주문 가능
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10mM in DMSO
Synonyms
11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Size
USA
독일 (EU)*
Price
Qty
1ml
R408290-1ml
1 재고 있음
—

US$132.90

US$154.90
저장 US$22.00 (14.20%)
Enter a quantity for the sizes you want to add.
🧪
Why this grade

Moligand™, 10mM in DMSO Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 30 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

개요

Information

Reserpine Reserpine is an inhibitor of multidrug efflux pumps, used as an antipsychotic and antihypertensive drug. Reserpine is an inhibitor of the vesicular monoamine transporter 2 (VMAT2).
In vitro

Reserpine inhibits efflux pumps and reduces sparfloxacin, moxifloxacin and ciprofloxacin IC50s and MICs by up to four-fold in 11, 21 and 48 of the 102 unrelated clinical isolates tested.

In vivo

Reserpine (5 mg/kg s.c.) reduces extracellular DA levels to 4% of basal values in intact rats. Reserpine (5 mg/kg s.c.) diminishes L-DOPA (50 mg/kg i.p.)-induced increases in extracellular dopamine levels to 16% of those obtained in denervated animals not pretreated with reserpine in 6-hydroxydopamine-lesioned rats. Reserpine causes a marked depletion of Vasotocin/oxytocin-neu-rophysin-like immunoreactivity (LI) and CRH-L1 in the median eminence of the rat. Reserpine significantly restores performance on the delayed response task in monkeys. Reserpine has little effect on performance of a visual discrimination task, a reference memory task which does not depend on the prefrontal cortex. Reserpine injection (one dose of 1 mg/kg s.c.) every other day for 3 days causes a significant increase in vacuous chewing, tongue protrusion and duration of facial twitching in rats, compared to the control. Reserpine results in a decreased glutamate uptake in the subcortical parts of rats. Reserpine (5 mg/kg) significantly increases vacuous jaw movements, and also reduces rearing behavior in all age groups of rats.
Cell Data

cell lines:Prostate(LNCap,PC3), Cervix(HeLa), Pancreas(ASPC1), Sarcoma(Saos-2)Ovary(OVCAR8), Stomach(NCI-N87), Melanoma(SKMEL3,A431, MALME3M), Colon(Colo205,SW620,HCT116), Breast(SKBR3,MDA-MB-453,MCF7), Lung(NCI-H82,MV522,NCI-H522), etc.

Concentrations:

Incubation Time:

Powder Purity:≥99%

Specifications

동의어
11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester
사양 및 순도
Moligand™, 10mM in DMSO
생화학 및 생리적 메커니즘
Reserpine is an inhibitor of multidrug efflux pumps, used as an antipsychotic and antihypertensive drug. Reserpine is an inhibitor of the vesicular monoamine transporter 2 (VMAT2).
보관 조건
Store at -80°C
배송
Dry ice packs + Cold packs
이 제품은 콜드 체인 배송이 필요합니다.지상 및 기타 경제 서비스는 사용할 수 없습니다.
등급
Moligand™
작업 유형
INHIBITOR
작동 메커니즘
Synaptic vesicular amine transporter inhibitor
제품 특성
ALogP
4
이름과 식별자
이성체 SMILES
CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC
WGK 독일
3
PubChem CID
5770
UN 번호
3077
포장 그룹
III
분자량
608.68
Beilstein
102014

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

관련 대상(인간)
ABCB1 Tchem Multidrug resistance protein 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC18A1 Tchem Chromaffin granule amine transporter (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC18A2 Tclin Synaptic vesicular amine transporter (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
인증서(CoA, COO, BSE/TSE 및 분석 차트)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
화학 및 물리적 특성
특정 회전[α]177° (C=1,DMF)
발화점(°F)22 °C
발화점(°C)22°C
자주 묻는 질문과 기사
Citations of This Product
솔루션 계산기
리뷰

고객 리뷰

Application Protocols

No vendor-validated application protocols are provided for this SKU.

  • Tested applications and dilutions: Not specified for this item; refer to CoA/Spec Sheet.

General preparation for small-molecule screening (literature/practice):

  • Prepare a 10–20 mM stock in anhydrous DMSO. Vortex and, if needed, sonicate briefly to ensure complete dissolution.
  • Aliquot into amber, low-bind tubes (e.g., 10–50 μL) and store at −80 °C. Avoid repeated freeze–thaw cycles.
  • For assay use, dilute into buffer to desired concentration, keeping final DMSO ≤1–2% v/v. Mix thoroughly and inspect for precipitation; filter through 0.22 μm if required.
  • Record lot number, stock concentration, and preparation date for traceability.

For analytical calibration uses, prepare serial dilutions in MeOH or ACN (optionally 0.1% formic acid) and store at −20 °C in amber autosampler vials for short-term runs.

Biological Roles

The following describes literature biology of reserpine as a natural product; it is provided for context only and does not constitute medical/clinical guidance.

  • Origin: monoterpenoid indole alkaloid isolated from Rauwolfia spp. (e.g., R. serpentina) (literature).
  • Molecular features relevant to biology: tertiary amine enables protonation and interaction with acidic residues; aromatic/indole system supports π–π and cation–π contacts; multiple methoxy/ester groups contribute to lipophilicity and membrane partitioning (literature).
  • Reported biochemical target: binds to vesicular monoamine transporters (e.g., VMAT), impairing vesicular uptake of monoamines in vitro (literature). This mechanism is commonly leveraged in basic research as a tool compound to modulate monoamine storage in cellular models.
  • Assay utility: used as a positive control in transporter binding assays and as a probe to stress-test assay dynamic range and signal stability due to its well-characterized activity profile (literature practice).
  • Metabolism/degradation (in vitro considerations): ester hydrolysis can occur; oxidative sensitivity of the indole may produce colored byproducts upon light/air exposure (literature). Protecting from light/oxidants preserves material integrity in biological testing.

Note: Aladdin Scientific supplies this compound strictly for research use only. No claims are made regarding therapeutic use, diagnosis, or any clinical application.

Buffer Applications

Reserpine is not a buffering agent and has very low water solubility, so classic buffer formulations are not applicable.

  • Preparing aqueous working solutions (research use):
    • Use a co‑solvent strategy: pre‑dissolve in DMSO (or ethanol), then dilute into the desired assay buffer (e.g., HEPES, PBS) keeping final co‑solvent ≤1–2% v/v to maintain biological compatibility (general practice).
    • Alternatively, prepare mildly acidic aqueous stocks (e.g., 0.01–0.05 M HCl) to increase solubility via salt formation; verify compatibility with your system and pH targets.
  • Filtration: if particulates form upon dilution, pass through a 0.22 μm PTFE or PES filter pre‑rinsed with the same solvent mixture.
  • Storage of buffered working solutions: generally prepare fresh; if unavoidable, store short‑term at 2–8 °C protected from light. For long‑term stocks, prefer frozen DMSO aliquots at −80 °C.

For buffer selection (pH control), rely on standard biological buffers (e.g., HEPES pH 7.4, phosphate pH 7.2–7.6); reserpine itself does not provide buffering capacity.

Green Alternatives

While the compound itself is fixed, greener choices can be made in its handling and formulation.

  • Preferred solvents for routine operations:
    • Use ethanol or isopropanol instead of chlorinated solvents where solubility allows (trade‑off: lower solubility vs improved EHS profile).
    • DMSO is acceptable for stocks; consider propylene carbonate or PEG‑400 for certain applications where DMSO is restricted (viscosity and assay interference may increase).
  • Workup and cleaning:
    • Replace dichloromethane with ethyl acetate for extractions when feasible; monitor for recovery due to solute lipophilicity.
    • Use aqueous ethanol for bench/surface decontamination to reduce volatile organic emissions.

Greener solvent comparison (literature-based, general):

  • DMSO: high solvency, low volatility; good EHS profile; may affect some assays at >1–2%.
  • Ethanol: renewable, biodegradable; flammable; moderate solvency.
  • Ethyl acetate: greener extraction solvent; limited for stock solutions due to volatility/solubility.
  • Chlorinated solvents (CHCl3/DCM): excellent solvency but poor EHS; reserve for cases where alternatives fail.

Implementation tips:

  • Validate assay performance with greener co‑solvents (e.g., ≤1% ethanol) before full deployment.
  • Minimize volumes and adopt microscale additions to limit solvent use.
  • Employ amber vials and low‑temperature, short‑path evaporations to reduce degradation and rework.
Pharmaceutical Uses

This product is sold for research use only. The notes below summarize non-clinical, formulation-oriented literature context without implying suitability for therapeutic use.

  • Historical context (literature): reserpine has been studied and previously used as an active pharmaceutical ingredient; however, this SKU is not qualified for clinical use.
  • Excipient/formulation considerations (research scale):
    • Solubility enhancement by salt formation with mineral acids (e.g., HCl) or by co‑solvent systems (ethanol, propylene glycol) has been described in the literature.
    • Solid-state sensitivity to light and heat suggests amber packaging and desiccation to limit degradation.
  • Analytical controls (development context):
    • Stability-indicating methods often rely on reversed-phase HPLC with UV detection around the near‑UV region; LC‑MS is commonly used to track hydrolysis/oxidation products (literature).
  • Regulatory status for this item: No pharmacopeial grade is claimed. Not specified for this item; refer to CoA/Spec Sheet.

Any work related to dosage forms, clinical evaluation, or human/animal administration is outside the permitted scope of this product and requires appropriate GMP-grade materials and regulatory oversight.

Physical Properties

Item-specific specs are not provided; values below summarize general literature characteristics of reserpine for planning purposes. Do not treat as acceptance criteria.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point: reported ~258–265 °C with decomposition (literature).
  • Boiling point: not applicable (decomposes before boiling at ambient pressure) (literature).
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable (solid).
  • pKa: tertiary amine expected to be weakly basic; reported pKa for the conjugate acid in the ~6–7 range (literature, method-dependent).
  • logP (octanol/water): reported in the 3–4 range, consistent with lipophilicity (literature).
  • Aqueous solubility: very low in neutral water; increases with acidification (salt formation) or with co-solvents (literature).
  • Organic solubility: soluble in DMSO and chloroform; sparingly to moderately soluble in methanol/ethanol; limited in acetonitrile and practically insoluble in alkanes (literature).
  • UV/Vis: indole chromophore and trimethoxybenzoyl ester provide π→π* absorption in near-UV; exact λmax is method/solvent dependent (literature).

Important: Where exact numerical specifications are required for qualification, use the lot-specific CoA/Spec Sheet. Literature properties can vary with salt form, hydration, and assay conditions.

Quality and Grades
  • Supplied grade: Moligand™ (screening library/ligand-discovery quality). This designation indicates material curated for small‑molecule screening and ligand discovery workflows, emphasizing reliable identity and suitability for assay preparation rather than application-specific pharmacopeial compliance.
  • Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Assay/ID controls typically associated with Moligand™ listings (general guidance):
    • Structure confirmation by NMR and/or HRMS.
    • Purity verification by HPLC/UPLC with UV or MS detection.
    • Lot traceability and barcoded vials for library management.
  • Stabilizers/inhibitors: None stated. Not specified for this item; refer to CoA/Spec Sheet.
  • UV cutoffs, water/peroxide/metal limits: Not specified for this item; refer to CoA/Spec Sheet.
  • What this means for users:
    • Suitable for biochemical assays, target binding studies, and reference controls in screening cascades.
    • If your application requires quantitative reference standard certification (e.g., compendial, isotope dilution, or stability‑indicating certificates), request the lot CoA or consider analytical/reference‑standard grades.
  • Documentation: For acceptance criteria (purity %, residual solvents, identity spectra), always rely on the lot‑specific CoA/Spec Sheet accompanying this SKU.
Reaction and Applications

This SKU is positioned primarily as a screening/ligand discovery compound; synthetic transformations on reserpine are specialized. The following guidance distinguishes common research uses from advanced derivatizations.

  • Research/screening uses (non-clinical):
    • Reference ligand/control compound in biochemical and cell‑free assay panels (literature practice for natural product tool compounds).
    • Analytical system suitability and retention marker for LC‑MS method development involving indole alkaloids.
  • Sample handling for assays:
    • Prepare 5–20 mM DMSO stocks, protect from light, and aliquot at −80 °C. Thaw on ice; dilute into assay buffer with ≤1–2% DMSO final.
  • Derivatization chemistry (literature context):
    • Ester hydrolysis/transesterification to access reserpic acid derivatives and alternate acyl esters (acidic or basic conditions; monitor to avoid decomposition).
    • O‑demethylation of aryl methoxy groups (e.g., BBr3 or AlCl3 systems) followed by re‑functionalization to probe SAR.
    • N‑oxide formation at the tertiary amine and subsequent Polonovski‑type manipulations as a handle for scaffold modification.
    • Hydrogenation or electrophilic substitutions on the indole motif under carefully controlled conditions.
  • Practical notes:
    • Multiple stereocenters and dense functionality demand mild, chemoselective conditions.
    • Protecting groups may be needed to preserve the ester and prevent indole oxidation.
    • Analytical monitoring by HPLC‑DAD and LC‑MS is recommended due to light/acid/base sensitivity.
Reaction Conditions

General, literature-based guidance for common manipulations on reserpine; actual conditions require optimization and rigorous analytical control.

  • Ester hydrolysis (to reserpic acid):
    • Mild basic conditions (e.g., K2CO3/MeOH, 0–25 °C) or acidic hydrolysis (e.g., HCl/MeOH). Monitor by HPLC; avoid prolonged exposure that promotes side reactions and demethylation.
  • Transesterification/re‑acylation:
    • DCC/DMAP or EDCI/DMAP in CH2Cl2 or EtOAc, 0–25 °C; yields are substrate- and steric‑dependent (literature).
  • O‑demethylation (aryl):
    • BBr3 in CH2Cl2 at −78 to 0 °C; quench cautiously. Alternative: AlCl3/thiophenol systems. Protect base‑sensitive moieties.
  • N‑oxidation/quaternization:
    • m‑CPBA (N‑oxide) in CH2Cl2, 0–25 °C; or alkyl halides for quaternary ammonium salt formation in acetonitrile/acetone.
  • Indole functionalization:
    • Vilsmeier–Haack formylation (POCl3/DMF, −20 to 0 °C) under protection to control regioselectivity; or electrophilic halogenation with NBS under buffered conditions.
  • Hydrogenation:
    • Pd/C or PtO2, 1–3 bar H2, alcohol solvent at 0–25 °C; risk of over‑reduction—strict monitoring required.

Common solvents: DCM, DMSO, MeOH/EtOH, EtOAc. Whenever possible, substitute greener options (EtOAc, MeOH) and employ low temperatures and short reaction times to limit degradation.

Note: The molecule is light/acid/base sensitive; apply amber glassware, anhydrous conditions, and minimal headspace oxygen. Reported yields vary widely and are substrate- and route-dependent (literature).

Safety and Handling
  • GHS/CLP classification, signal word, and pictograms: Not specified for this item; refer to the SDS for authoritative hazard information.
  • General hazards (literature/good practice): complex indole alkaloid; avoid ingestion, inhalation of dust, and skin/eye contact. Handle in a chemical fume hood.
  • Light and heat sensitivity: reserpine is known to be light sensitive and may degrade upon prolonged exposure; minimize light and maintain cold chain per storage guidance (literature).
  • Incompatibilities: strong oxidizers and strong acids/bases may promote degradation (ester cleavage, oxidation). Avoid reactive acylation/alkylation agents unless intended (general chemistry guidance).
  • PPE: lab coat, nitrile gloves, splash goggles; consider double-gloving for extended handling. Use antistatic measures to limit powder aerosolization.
  • First aid (overview; defer to SDS):
    • Inhalation: move to fresh air; seek medical evaluation if symptoms persist.
    • Skin: wash with soap and water; remove contaminated clothing.
    • Eyes: rinse cautiously with water for several minutes; remove contact lenses if present and easy to do.
    • Ingestion: rinse mouth; seek medical attention.
  • Spill/cleanup: avoid dust; gently cover with inert absorbent, transfer to waste. Decontaminate surfaces with ethanol or dilute detergent.
  • Waste: collect as halogen-free organic solid waste unless otherwise required; follow institutional and local regulations.
  • Transport/storage notes: Shipped on dry ice/cold packs. Store at −80 °C as specified in Product Data; keep container tightly closed, desiccated, and protected from light.
Solvent Selection

Reserpine is lipophilic with very low intrinsic water solubility and a basic tertiary amine, favoring dissolution in polar aprotic organics or under acidic conditions.

  • Primary stock solvent (screening workflows):
    • DMSO: typically dissolves ≥10 mM with gentle warming/sonication (literature/practice). Stable for aliquoted frozen stocks.
  • Alternative solvents:
    • Methanol, ethanol, isopropanol: workable at lower concentrations; useful as co‑solvents for aqueous dosing solutions (literature).
    • Chloroform and dichloromethane: excellent solubility for preparative work; avoid for bioassays and prefer greener options when possible.
    • Acetonitrile: variable solubility; can be used as minor co‑solvent.
  • Aqueous formulations:
    • Use co‑solvent (e.g., 0.5–2% DMSO or ethanol) and/or acidify slightly (e.g., 0.01–0.05 M HCl) to form soluble salt for stock solutions; filter if needed (literature guidance). Verify assay compatibility.
  • Polarity/miscibility (literature):
    • Polarity class: polar aprotic (for recommended solvents), solute is moderately lipophilic (logP ~3–4).
    • Miscible: DMSO, alcohols; immiscible with alkanes.
  • Practical tips:
    • Prepare small, single‑use aliquots to avoid freeze–thaw.
    • Protect from light during dissolution and dispensing.
    • For LC/MS sample prep, prefer MeOH or ACN with 0.1% formic acid to aid ionization; avoid basic eluents that may induce transesterification over time.
Storage and Reconstitution
  • Storage conditions (as provided): Store at −80 °C. Shipments are made on dry ice packs + cold packs to maintain the cold chain.
  • Container handling:
    • Keep tightly closed, desiccated, and protected from light (amber secondary containment recommended).
    • Minimize headspace and temperature cycling.
  • Stability notes (literature/practice): reserpine is light sensitive and may degrade upon exposure to heat, light, or moisture. Maintain at low temperature and prepare small aliquots.

Reconstitution guidelines (research use):

  • Solvent: Use anhydrous DMSO for primary stocks (e.g., 10–20 mM). Ethanol or methanol may be used at lower concentrations if compatible with the intended use.
  • Procedure:
    1. Allow vial to equilibrate to room temperature in the dark before opening to prevent moisture condensation.
    2. Add pre-warmed solvent (if needed), cap, vortex, and briefly sonicate until fully dissolved.
    3. Dispense single-use aliquots into amber tubes; immediately return unused material to −80 °C.
  • Working solutions:
    • Prepare fresh by diluting stock into assay buffer, maintaining final co‑solvent ≤1–2% v/v. If precipitation occurs, adjust co‑solvent or mildly acidify as compatible.
  • Freeze–thaw:
    • Avoid repeated freeze–thaw cycles. Thaw aliquots on ice and use promptly; discard any degraded or precipitated solutions.

For definitive stability periods and acceptance criteria, consult the lot-specific CoA/Spec Sheet and SDS.

Structure and Identity

Reserpine is a highly functionalized monoterpenoid indole alkaloid widely used as a small‑molecule reference standard and screening ligand in discovery collections.

  • SKU: R408290
  • CAS: 50-55-5
  • CID (PubChem): 5770
  • Grade: Moligand™ (screening library quality)
  • Molecular formula: C33H40N2O9 (literature)
  • Molecular weight: ~608.69 g/mol (literature)
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (descriptive):

  • Contains an indole-derived system fused into a polycyclic, oxygenated cage-like framework typical of ajmaline/yohimbine-family alkaloids (literature).
  • Functional groups: tertiary amine (basic center), multiple O-methyl ethers, and ester linkages including a 3,4,5‑trimethoxybenzoyl ester (literature).
  • Stereochemistry: multiple defined stereocenters across the polycyclic core; exists as a single, well-defined natural stereochemical configuration (literature).
  • 2D depiction in words: an indole-like aromatic ring annulated to a multi-ring aliphatic scaffold bearing an internal tertiary amine; several methoxy substituents decorate both the aryl ester and the aliphatic oxygenated rings (literature).

Note: Exact identifiers beyond CAS/CID are not specified in the product data; consult the item’s CoA for definitive line notations.

Synthetic Utility

Reserpine’s dense functionality and defined stereochemistry make it a useful platform for probe development and SAR exploration in natural‑product‑inspired chemistry (literature context).

Key functional elements and reactivity:

  • Tertiary amine: amenable to quaternization, N‑oxide formation, or reductive manipulations to tune polarity and binding.
  • Ester linkages: hydrolyzable to reserpic acid; re‑esterification enables installation of varied acyl groups (including bioisosteres) for prodrug or probe design (literature).
  • Aryl methoxy groups: sites for O‑demethylation followed by diversification (e.g., ether/ester formation) to adjust electronics and H‑bonding.
  • Indole motif: electrophilic substitution (e.g., Vilsmeier formylation under protected conditions) or controlled hydrogenation/aromatization sequences.

Retrosynthetic/value:

  • Serves as a benchmark scaffold for testing late‑stage functionalization strategies on complex alkaloids.
  • A comparator in method development for chemoselective acylation, C–H activation near heteroatoms, and photoredox transformations in polyfunctional settings.

Analytical considerations:

  • Use multi-detector HPLC (DAD + MS) to ensure selectivity; degradation can masquerade as partial conversion.
  • Protect sensitive positions during harsh steps; prefer orthogonal protection to preserve stereochemical integrity (literature best practices).
Target Specificity

Item-specific target details (e.g., protein target, binding constants, species reactivity) are not provided for this SKU.

  • Target/epitope/clone/isotype: Not specified for this item; refer to CoA/Spec Sheet.

General literature context (for orientation only): reserpine is commonly used as a tool compound in studies of vesicular monoamine transporters; however, no binding parameters or selectivity data are specified for this product listing.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.